Wed.Jun 12, 2024

article thumbnail

BMS chief Boerner says company is still hungry for deals after spending more than $20B on M&A last year

Fierce Pharma

As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target | As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target comes along.

Pharma 344
article thumbnail

Reimagining the Language and Translation Space for Patients

MedCity News

Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening. The post Reimagining the Language and Translation Space for Patients appeared first on MedCity News.

Patients 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amid FTC crackdown, judge says Teva inhaler patents are 'improperly listed' in FDA Orange Book

Fierce Pharma

After being called out on some intellectual property claims late last year, Teva has fallen victim to the Federal Trade Commission’s (FTC’s) ongoing crusade against questionable drug patents. | A federal judge in New Jersey ruled that five of Teva’s patents on the metered dose inhaler for its asthma med ProAir HFA are “improperly listed” in the FDA’s Orange Book.

FDA 336
article thumbnail

Who Should Be Responsible for Rationing GLP-1s?

MedCity News

There is a shortage of GLP-1s in the U.S. But experts have differing opinions on whose responsibility it is to be rationing the drugs. The post Who Should Be Responsible for Rationing GLP-1s? appeared first on MedCity News.

124
124
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Junshi, Coherus' PD-1 inhibitor Loqtorzi scores in phase 3 liver cancer trial

Fierce Pharma

Junshi revealed that a phase 3 trial of Loqtorzi plus Avastin prolonged the survival of first-line patients with hepatocellular carcinoma.

Patients 323
article thumbnail

Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause

MedCity News

Avidity Biosciences’ RNA therapy for facioscapulohumeral muscular dystrophy has preliminary clinical data showing it knocked down expression of a gene that causes this rare disease. More details will be presented at a medical conference this week. The post Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause appeared first on MedCity News.

Medical 122

More Trending

article thumbnail

Why Is Moon Surgical’s New Commercial Robot System Important?

MedCity News

This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems. The post Why Is Moon Surgical’s New Commercial Robot System Important?

FDA 119
article thumbnail

New study reveals how brain cell communication is linked to Alzheimer’s disease

PharmaTimes

Two support cells, microglia and astrocytes, were found to communicate with each other

118
118
article thumbnail

Developing the EU’s first intestinal microbiota-based biologic

European Pharmaceutical Review

Since 2018, biotech company Mikrobiomik has been researching, development and producing innovative biological medicines based on the human microbiome. We are proud to be the first company planning to market MBK-01, the EU’s first biologic based on intestinal microbiota, full spectrum purified intestinal microbiota (FSPIM), in the form of lyophilised capsules for oral administration.

Safety 111
article thumbnail

ICL receives £10m donation to advance heart and lung research

PharmaTimes

The donation will help scientists and clinicians collaborate and make new advances in research

109
109
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

NICE declines to look again at depression drug Spravato

pharmaphorum

Johnson & Johnson has slammed a decision by NICE not to carry out a new appraisal of its antidepressant Spravato, claiming it has “grave concern” about access to new mental health treatments through NHS England.

108
108
article thumbnail

For Community Hospitals, Curing Payment Confusion Requires Patient Friendly Solutions

MedCity News

Strengthening patient financial education with the help of digital payment tools could be key to consumer engagement and cash recovery. The post For Community Hospitals, Curing Payment Confusion Requires Patient Friendly Solutions appeared first on MedCity News.

Patients 108
article thumbnail

Pharma Pulse 6/12/24: The Healthcare System is Changing—So How Should We Respond?, What the Apple-OpenAI Deal Means for Four Tech Titans & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Data sharing will be key in repairing the UK clinical ecosystem

Pharmaceutical Technology

Lord James O'Shaughnessy, the former health minister, outlines places where the UK is falling behind other countries with clinical research.

105
105
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

ABPI embraces proposals for pharma’s growth ahead of UK elections

European Pharmaceutical Review

The Association of the British Pharmaceutical Industry (ABPI) has welcomed proposals from the Conservative and Unionist Party’s recently published Manifesto for the UK’s 2024 general election. We encourage other parties to come forward with equally specific proposals to boost the sector, so that the progress of recent years can be maintained” For example, this includes plans to accelerate NHS patient access to new medicines, which propose to “ remove bureaucratic obstacles to the use of

article thumbnail

Behind the powerful computations, AI’s role in pharma is still beset by challenges

PharmaVoice

Small biotechs are saving time and money leveraging AI to develop new drugs, but incomplete data and disease complexity remain hurdles for the space.

Pharma 95
article thumbnail

Siegfried to boost drug substances offering with new acquisition

Pharmaceutical Technology

Siegfried has announced the signing of binding agreements with Curia Global to acquire an early-phase CDMO site in Grafton, Wisconsin, US.

81
article thumbnail

Therapeutic Delivery for Brain-related Conditions

PharmaTech

At BIO 2024 in San Diego, John Dunlop, PhD, chief scientific officer at Aliada Therapeutics, sat down for an interview with Pharmaceutical Technology to discuss the firm’s MODEL platform and its potential impact on therapeutic delivery for brain-related conditions.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Anti-obesity drugs will be 2024’s defining trend

Pharmaceutical Technology

GlobalData’s newest update notes the impact of the growing anti-obesity market, apersonalised medicines, real-world evidence, and cell and gene therapies.

article thumbnail

The Role of CRM Integration in Modern Lead Generation

Scott’s Directories

In today’s fast-paced digital world, integrating Customer Relationship Management (CRM) systems with lead generation tools is a game-changer for businesses, especially in the healthcare industry. This integration is vital for streamlining the process of capturing, tracking, and nurturing leads, ensuring that no opportunity slips through the cracks.

CRM 52
article thumbnail

Merck KGaA invests in Life Science business facility in Germany

Pharmaceutical Technology

Merck KGaA announced a €62m ($66.

64
article thumbnail

Flexibility in Outsourcing Models (BIO 2024)

PharmaTech

The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.

52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Bankrupt Mithra cashes in on remaining assets for $188.2m

Pharmaceutical Technology

Gedeon Richter gains rights to Mithra’s estetrol range in addition to subsidiaries Neuralis and Estetra.

52
article thumbnail

Determining the Source of Endocrine Therapy Nonadherence

Pharmaceutical Commerce

A retrospective cohort study investigates the characteristics of female patients with localized breast cancer that are associated with this nonpersistence.

article thumbnail

Thinking outside of the box: Digitising pharmacy dispensing labels

Pharmaceutical Technology

Written Medicine is a digital solution that provides bilingual dispensing labels, described in a presentation at the NHS ConfedExpo conference in Manchester.

article thumbnail

A Novel Approach to Therapeutic Delivery Across the Blood-Brain Barrier

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Study finds most patients in TARGET-NASH registry meet revised MASLD criteria

Pharmaceutical Technology

In 2023, MASLD replaced the umbrella term of nonalcoholic fatty liver disease (NAFLD) to avoid the potentially stigmatising language of the former name.

article thumbnail

Study Suggests Individuals Born Preterm Are More Likely to Have Lower Incomes in Adulthood

PharmExec

Investigators followed a group of people born from 1990-1996 to assess whether the association between preterm birth and income differs according to family socioeconomic status at birth.

52
article thumbnail

Discovery Life Sciences Builds New Site in Greater Boston Area

Pharmaceutical Commerce

The 53,000 square-foot facility is expected to become a Northeastern biotech hub, and will be home to various CGT services.

52
article thumbnail

CordenPharma and Certest Team Up on Ionizable Lipids to Develop LNP Formulations

PharmaTech

CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A